Akari Therapeutics PLC logo

Akari Therapeutics PLC - ADR

0
FRA:CLA (USA)   ADR
€ 2.08 (-6.31%) Nov 12
At Loss
Market Cap:
€ 25.25M ($ 26.67M)
Enterprise V:
€ 22.26M ($ 23.51M)
Volume:
-
Avg Vol (2M):
10.00
Trade In:

Akari Therapeutics PLC Valuation Measures